The report noted that while renminbi fundraising dropped in monetary terms in 2013, its share of the market climbed 12 per cent to 77 per cent.
It also said that there has been an improvement in private equity and venture capital regulations in the country.
Lats month it was reported that two private equity-backed businesses, Zhejiang Wolwo Pharma and Neway Valve, were given the go-ahead to list on mainland Chinese stock exchanges following a year-long moratorium on IPOs.
Three other Chinese companies were approval to list in mainland China, which will give a boost to the 750-plus other businesses with pending IPO.
Copyright © 2014 AltAssets